Dr. Li brings more than 25 years’ experience as a biometrics leader in the biopharmaceutical industry.
Dr. Li most recently served as Senior Vice President, Biometrics, at Marinus Pharmaceuticals, creating and leading a team which was responsible for all activities pertinent to statistics, data management and programming. He played a leadership role in the successful submission and approval of Ztalmy®, a first-in-class treatment for seizures in CDKL5 deficiency disorder (CDD). Over his career, Dr. Li held global Biometrics roles of increasing responsibility at Forest Laboratories (now AbbVie), Astra Zeneca, and other medium and small sized pharmaceutical and biotech companies and was involved in over ten NDA/sNDA submissions with high approval rates.
Dr. Li holds a PhD in statistics from University of Maryland and a bachelor’s degree in mathematics from Henan Normal University, China.